Clinical Trial Update: Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nicotine for pain associated with chemotherapy-induced peripheral neuropathy was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain
• Neuropathy
• Peripheral Neuropathy

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Neuropathy, Peripheral Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2023-11-08